1Strassels S A, Sullivan S D. Clinical and economic considerations of vaccination against vaficella[ J ]. Pharmacotherapy, 1997,17( 1 ) : 133- 139.
2Diez - Domingo J, Ridao M, Latour J, et al. A Cost - benefit analysis of routine varicella vaccination in Spain[J]. Vaccine, 1999, 17( 11 -12) : 1306 - 1311.
3Preblud S R, Orenstein W A, Koplan J P, et al. A benefit - cost analysis of a childhood varieella vaccination programme[J]. Postgrad Med J, 1985,61(Supp14):17 - 22.
4Huse D M, Meissner H C, Lacey M J, et al.Childhood vaccination against chickenpox: an analysis of benefits and costs [J ]. J Pediatr,1994,124(6) :869 - 874.
5Beutels P, Clara G, Tormans E, et al. Cost and benefit analysis of routine varicella vaccination in German Children [J]. JID, 1996, 174(Suppl 3) :335 - 341.
6Brisson M, Edmunds W J. The cost - effectiveness of varicella vaccination in Canada[J]. Vaccine, 2002, 20(7 - 8) : 1113 - 1125.
7Scuffham P A, Lowin A V, Burgess M A. The cost - effectiveness of varicella vaccine programs for Australia[ J ]. Vaccine, 1999, 18 (5-6) :407 - 415.
8Coudeville L, Paree F, Lebrun T, et al. The value of varicclla vaccination in healthy children: cost - benefit analysis of the situation in Franee[J]. Vaccine, 1999, 17(2):142 - 151.
9Smith K J, Roberts M S. Cost - effectiveness of vaccination strategies in adults without a history of chickenpox [ J ] . Am J Med, 2000, 108(9) :723 - 729.
10Gayman J .A cost - effectiveness model for analyzing two varicella vaccination strategies [ J ] . Am Health Syst Pharm, 1998, 55(24Suppl 4) : 4 - 8.
